Skip Navigation LinksIIBR > Publications

  Publications

 

 

Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.mdpi.com/2077-0383/11/9/2649Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 YearsBar-Haim E, Eliakim-Raz N, Stemmer A, Cohen H, Elia U, Ness A, Awwad M, Ghantous N, Moskovits N, Rotem S, Stemmer S2022Journal of clinical Medicine
Elucidation of synthetic N-benzyl cathinone structures using chemical derivatization and liquid chromatography–tandem mass spectrometry analysis<img alt="" src="/Style%20Library/IIBR/img/svg-icons/chimical.svg" style="BORDER:0px solid;" />https://www.sciencedirect.com/science/article/pii/S246817092200025X#!Elucidation of synthetic N-benzyl cathinone structures using chemical derivatization and liquid chromatography–tandem mass spectrometry analysisShamai-Yamin T, Shifrovich A, Madmon M, Belay C, Prihed H, Blanca M, Hindi A, Zafrani Y, Berliner A, Weissberg A2022Forensic Chemistry
Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.nature.com/articles/s41467-022-29896-zGenome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2Israeli M, Finkel Y, Yahalom-Ronen Y, Paran N, Chitlaru T, Israeli O, Cohen-Gihon I, Aftalion M, Falach R, Rotem S, Elia U, Nemet I, Kliker L, Mandelboim M, Beth-Din A, Israely T, Cohen O, Stern-Ginossar N, Bercovich-Kinori A2022Nature Communacations
Optimization of VSV-ΔG-spike production process with the Ambr15 system for a SARS-COV-2 vaccine<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://onlinelibrary.wiley.com/doi/10.1002/bit.28088Optimization of VSV-ΔG-spike production process with the Ambr15 system for a SARS-COV-2 vaccineRosen O, Jayson A, Goldvaser M, Dor E, Monash A, Levin L, Cherry L, Lupu E, Natan N, Girshengorn M, Epstein E2022Biotechnology & Bioengineering
Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.mdpi.com/1999-4915/14/4/688Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague Yaron Vagima Y, Gur D, Aftalion M, Moses S, Levy Y, Makovitzki A, Holtzman T, Oren Z, Segula Y, Fatelevich E, Tidhar A, Zauberman A, Rotem S, Mamroud E, Steinberger-Levy I2022Viruses
Transcriptome analysis of lungs in a mouse model of severe COVID-19 <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.frontiersin.org/articles/10.3389/fviro.2022.848465/fullTranscriptome analysis of lungs in a mouse model of severe COVID-19 Cohen-Gihon I, Israeli O,Tidhar A, Sapoznikov A, Yentl Evgy, Stein D, Aftalion M, Gur D, Orr I, Zvi A, Sabo T, Kronman C, Falach R2022Front.Virol
Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.mdpi.com/2073-4468/11/1/21Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 NeoepitopeMechaly A, Diamant E, Alcalay R, Ben David A, Dor E, Torgeman A, Barnea A, Girshengorn M, Levin L, Epstein E, Tennenhouse A, Fleishman S, Zichel R, Mazor O 2022Antibodies
T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.mdpi.com/1999-4915/14/2/347T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of ConcernCohen H, Rotem S, Elia U, Bilinsky G, Levy I, Chitlaru T, Bar-Haim E2022Viruses
Revisiting SARS-CoV-2 environmental contamination by COVID-19 patients: The Omicron variant does not differ from previous strains<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.sciencedirect.com/science/article/pii/S1201971222001394?via%3DihubRevisiting SARS-CoV-2 environmental contamination by COVID-19 patients: The Omicron variant does not differ from previous strainsGlinert I, Ben-Shmuel A, Szwartcwort-Cohen M, Beth-din A, Laskar O, Barlev-Gross M, Melamed S, Arbell N, Levy H, Horowitz N, Weiss S2022The International Journal of Infectious Diseases
SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccine<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.sciencedirect.com/science/article/pii/S0166093422000453?via%3DihubSARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccineRosen O, Jayson A, Eyal Dor E, Epstein E, Makovitzki A, Cherry L, Lupu E, Monash A, Borni S, Baruchi T, Laskar O, Shmaya S, Rosenfeld R, Levy Y, Schuster O, Feldberg L2022The Journal of Virological Methods
An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestis<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.mdpi.com/2076-0817/11/2/255An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestisMakdasi E, Atiya-Nasagi Y, Gur D, Zauberman A, Schuster O, Glinert I, Shmaya S, Milrot E, Levy H, Weiss S, Chitlaru T, Mamroud E, Laskar O2022Pathogens
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYahalom-Ronen Y,Erez N,Fisher M,Tamir H,Politi B, Achdout H, Melamed S, Glinert I, Weiss S, Cohen-Gihon I, Israeli O, Izak M, Mandelboim M, Caraco Y, Madar-Balakirski N, Mechaly A, Shinar A, Zichel R, Cohen D, Beth-Din A, Zvi A,Marcus H, Israely T,Paran N2022Vaccines
Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.mdpi.com/1999-4915/14/2/189Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 InfectionTamir H, Melamed S, Erez N, Politi B, Yahalom-Ronen Y, Achdout H, Lazar S, Gutman H, Avraham R, Weiss S, Paran N, Israely T2021Viruses
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://www.nature.com/articles/s41467-021-26113-1Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity Achdout H, Vitner E, Politi B, Melamed S, Yahalom-Ronen Y, Tamir H, Erez N, Avraham R, Weiss S, Cherry L, Bar-Haim E, Makdasi E, Gur D, Aftalion M, Chitlaru T, Vagima Y, Nir Paran, Israely T2021Nature Communacations
Coupling immuno-magnetic capture with LC–MS/MS(MRM) as a sensitive, reliable, and specific assay for SARS-CoV-2 identification from clinical samples<img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" />https://link.springer.com/article/10.1007%2Fs00216-021-03831-5Coupling immuno-magnetic capture with LC–MS/MS(MRM) as a sensitive, reliable, and specific assay for SARS-CoV-2 identification from clinical samplesSchuster O, Atiya-Nasagi Y, Rosen O, Zvi A, Glinert I, Ben Shmuel A, Weiss S, Laskar O, Feldberg L 2021Analytical and Bioanalytical Chemistry